Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Knee Osteoarthritis
Interventions
DRUG

placebo

"Pharmaceutical form:injection~Route of administration: intra-articular"

DRUG

SAR113945

"Pharmaceutical form:injection~Route of administration: intra-articular"

Trial Locations (1)

532-0003

Investigational Site Number 392001, Osaka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY